These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 24284393)

  • 1. The role of crowded physiological environments in prion and prion-like protein aggregation.
    Ma Q; Hu JY; Chen J; Liang Y
    Int J Mol Sci; 2013 Oct; 14(11):21339-52. PubMed ID: 24284393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in prion and prion-like protein aggregation.
    Yi CW; Xu WC; Chen J; Liang Y
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):520-6. PubMed ID: 23709368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crowded cell-like environment accelerates the nucleation step of amyloidogenic protein misfolding.
    Zhou Z; Fan JB; Zhu HL; Shewmaker F; Yan X; Chen X; Chen J; Xiao GF; Guo L; Liang Y
    J Biol Chem; 2009 Oct; 284(44):30148-58. PubMed ID: 19748895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.
    Goedert M; Falcon B; Clavaguera F; Tolnay M
    Curr Neurol Neurosci Rep; 2014 Nov; 14(11):495. PubMed ID: 25218483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prions: generation and spread versus neurotoxicity.
    Halliday M; Radford H; Mallucci GR
    J Biol Chem; 2014 Jul; 289(29):19862-8. PubMed ID: 24860100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegeneration. Could they all be prion diseases?
    Miller G
    Science; 2009 Dec; 326(5958):1337-9. PubMed ID: 19965731
    [No Abstract]   [Full Text] [Related]  

  • 7. The contrasting effect of macromolecular crowding on amyloid fibril formation.
    Ma Q; Fan JB; Zhou Z; Zhou BR; Meng SR; Hu JY; Chen J; Liang Y
    PLoS One; 2012; 7(4):e36288. PubMed ID: 22558423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.
    Jucker M; Walker LC
    Nature; 2013 Sep; 501(7465):45-51. PubMed ID: 24005412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trafficking and degradation pathways in pathogenic conversion of prions and prion-like proteins in neurodegenerative diseases.
    Victoria GS; Zurzolo C
    Virus Res; 2015 Sep; 207():146-54. PubMed ID: 25645281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion-like mechanisms in neurodegenerative diseases.
    Frost B; Diamond MI
    Nat Rev Neurosci; 2010 Mar; 11(3):155-9. PubMed ID: 20029438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prion 2018 round tables (II): Aβ, tau, α-synuclein… are they prions, prion-like proteins, or what?
    Eraña H
    Prion; 2019 Jan; 13(1):41-45. PubMed ID: 30646820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the Molecular Jam: How Crowding Shapes Protein Aggregation in Neurodegenerative Disorders.
    Patel SP; Nikam T; Sreepathi B; Karankar VS; Jaiswal A; Vardhan SV; Rana A; Toga V; Srivastava N; Saraf SA; Awasthi S
    ACS Chem Biol; 2024 Oct; 19(10):2118-2130. PubMed ID: 39373539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse models for studying the formation and propagation of prions.
    Watts JC; Prusiner SB
    J Biol Chem; 2014 Jul; 289(29):19841-9. PubMed ID: 24860095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target.
    Holmes BB; Diamond MI
    J Biol Chem; 2014 Jul; 289(29):19855-61. PubMed ID: 24860099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of proteins in neurodegenerative disease].
    Szwed A; Miłowska K
    Postepy Hig Med Dosw (Online); 2012 Apr; 66():187-95. PubMed ID: 22706103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the Protein Seeds of Neurodegeneration using Real-Time Quaking-Induced Conversion Assays.
    Manca M; Kraus A
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32854212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The propagation of prion-like protein inclusions in neurodegenerative diseases.
    Goedert M; Clavaguera F; Tolnay M
    Trends Neurosci; 2010 Jul; 33(7):317-25. PubMed ID: 20493564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of α-synuclein and Tau: A molecular conspiracy in neurodegeneration?
    Yan X; Uronen RL; Huttunen HJ
    Semin Cell Dev Biol; 2020 Mar; 99():55-64. PubMed ID: 29738880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration.
    Goedert M; Masuda-Suzukake M; Falcon B
    Brain; 2017 Feb; 140(2):266-278. PubMed ID: 27658420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.